SANDOSTATIN LAR 10 mg Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sandostatin lar 10 mg

novartis pharma gmbh - germania - octreotidum - pulb. si solv. pt. susp. inj. - 10mg - hormoni hipotalamici hormoni anticrestere

SANDOSTATIN LAR 20 mg Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sandostatin lar 20 mg

novartis pharma gmbh - germania - octreotidum - pulb. si solv. pt. susp. inj. - 20mg - hormoni hipotalamici hormoni anticrestere

SANDOSTATIN LAR 30 mg Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sandostatin lar 30 mg

novartis pharma gmbh - germania - octreotidum - pulb. si solv. pt. susp. inj. - 30mg - hormoni hipotalamici hormoni anticrestere

ARIMIDEX 1 mg Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

arimidex 1 mg

haupt pharma muenster gmbh - germania - anastrozolum - compr. film. - 1mg - antagonisti hormonali si substante inrudite inhibitori enzimatici

ABACAVIR/LAMIVUDINA MYLAN PHARMA 600 mg/300 mg Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

abacavir/lamivudina mylan pharma 600 mg/300 mg

mcdermott laboratories limited t/a - irlanda - abacavirum+lamivudinum - compr. film. - 600mg/300mg - antivirale cu actiune directa antivirale pentru tratamentul infectiei cu hiv, combinatii

ABACAVIR/LAMIVUDINA MYLAN PHARMA 600 mg/300 mg Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

abacavir/lamivudina mylan pharma 600 mg/300 mg

mcdermott laboratories limited t/a - irlanda - abacavirum+lamivudinum - compr. film. - 600mg/300mg - antivirale cu actiune directa antivirale pentru tratamentul infectiei cu hiv, combinatii

Clopidogrel Viatris (previously Clopidogrel Taw Pharma) Europese Unie - Roemeens - EMA (European Medicines Agency)

clopidogrel viatris (previously clopidogrel taw pharma)

viatris limited - clopidogrel besilate - peripheral vascular diseases; stroke; myocardial infarction - agenți antitrombotici - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). supradenivelare de segment st infarct miocardic acut, în asociere cu aas în tratați medical, eligibili pentru tratamentul trombolitic. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. pentru informații suplimentare vă rugăm să consultați secțiunea 5.

OCTREOTIDA TEVA 10 mg Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

octreotida teva 10 mg

teva pharmaceuticals europe b.v. - olanda - octreotidum - pulb. si solv. pt. susp. inj. cu elib. prel. - 10mg - hormoni hipotalamici hormoni anticrestere

OCTREOTIDA TEVA 20 mg Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

octreotida teva 20 mg

teva pharmaceuticals europe b.v. - olanda - octreotidum - pulb. si solv. pt. susp. inj. cu elib. prel. - 20mg - hormoni hipotalamici hormoni anticrestere

OCTREOTIDA TEVA 30 mg Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

octreotida teva 30 mg

teva pharmaceuticals europe b.v. - olanda - octreotidum - pulb. si solv. pt. susp. inj. cu elib. prel. - 30mg - hormoni hipotalamici hormoni anticrestere